No specific studies have reviewed the efficacy of PSMA PET-CT in intraductal PCa, however several articles express concerns over their accuracy and suggest the addition of mpMRI or FDG PET to more accurately stage and monitor patients [85,86]. The gene discussed is FOLH1; the disease is posterior cortical atrophy.